Adore Meditech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
- Revenue Growth -88.46%
- Profit Growth 97.99%
- Ebitda -640.12%
- Net Worth 1.25%
- Total Assets -1.65%
About Adore Meditech
Adore Meditech Private Limited (AMPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 May 2014 and has a history of Ten years and eight months. Its registered office is in Chandigarh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Harish Singla and Rajeev Kalia serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232CH2014PTC035076
-
Company No.
035076
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 May 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Adore Meditech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harish Singla
|
Director | 14-Jul-2021 | Current |
|
Rajeev Kalia
|
Director | 21-Jun-2014 | Current |
Financial Performance of Adore Meditech.
Adore Meditech Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 88.46% decrease. The company also saw a substantial improvement in profitability, with a 97.99% increase in profit. The company's net worth moved up by a moderate rise of 1.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adore Meditech?
In 2021, Adore Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Residency Overseas LlpHarish Singla is a mutual person
-
Marketwave Meditech Private Limited
Harish Singla and Rajeev Kalia are mutual person
-
Marketwave Agencies Private Limited
Harish Singla is a mutual person
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Oct 2014 | Yes Bank Limited | ₹1.00 Cr | Open |
How Many Employees Work at Adore Meditech?
Unlock and access historical data on people associated with Adore Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adore Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adore Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
